Tweet
Tate & Lyle (OTCMKTS:TATYY) was downgraded by Zacks Investment Research from a "buy" rating to a "hold" rating in a report issued on Wednesday.
According to Zacks, "Tate & Lyle Ventures and Agri Investment Fund have co-led a 3.5m investment into Fugeia, a newly formed functional food technology business with a focus on gut health. " Get Tate & Lyle alerts:
TATYY has been the topic of a number of other research reports. ValuEngine raised Tate & Lyle from a "sell" rating to a "hold" rating in a report on Tuesday, May 29th. Jefferies Financial Group downgraded Tate & Lyle from a "buy" rating to a "hold" rating in a report on Wednesday, June 13th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and two have given a buy rating to the stock. The stock has an average rating of "Hold" and a consensus target price of $38.00. Shares of TATYY stock opened at $32.90 on Wednesday. The firm has a market capitalization of $3.88 billion, a price-to-earnings ratio of 12.37, a price-to-earnings-growth ratio of 4.06 and a beta of 0.46. Tate & Lyle has a fifty-two week low of $29.39 and a fifty-two week high of $38.25.
Tate & Lyle Company Profile
Tate & Lyle Plc engages in the provision of ingredients and solutions to the food, beverage and other industries. It operates through the following segments: Food & Beverage Solutions, Sucralose, and Primary Products. The Food & Beverage Solutions and Sucralose segment provides solutions for customers that meet consumer demand for healthier and tastier food and drink.
Get a free copy of the Zacks research report on Tate & Lyle (TATYY)
For more information about research offerings from Zacks Investment Research, visit Zacks.com Receive News & Ratings for Tate & Lyle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tate & Lyle and related companies with MarketBeat.com's FREE daily email newsletter 